Polderdijk, Stéphanie G. I.
Huntington, James A.
Article History
Received: 9 February 2018
Accepted: 18 May 2018
First Online: 8 June 2018
Competing Interests
: SGIP and JAH are shareholders in ApcinteX Ltd, the company developing the KRK variant (SerpinPC) for the treatment for haemophilia.